Livongo Health LVGO shares are trading higher on Tuesday after Stephens initiated coverage on the stock with an Overweight rating and $95 price target. The company also raised its second-quarter sales guidance from $73-$75 million to $86-$87 million.
Livongo Health provides a data science and technology-enabled platform for detection of diabetes. Its additional solutions include Livongo for Hypertension, Livongo for Prediabetes and Weight Management, and Livongo for Behavioral Health by myStrength.
The company's clients comprise of employers, health plans, government entities, and labor unions. Its operations are primarily located in the U.S.
Livongo Health shares were trading up 21.15% at $94.05 at the time of publication on Tuesday. The stock has a 52-week high of $94.10 and a 52-week low of $15.12.
Related Links:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
